Home
Conditions
RNA Virus Infections

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,765 public trials 829 recruiting studies

Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities

NCT03823209

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: AIDS TaskForce of Greater Cleveland Cleveland, Ohio, United States

Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Spirulina Oral Supplement for Enhancing Host Resilience to Virus Infection

NCT05447078

Conditions: Healthy Volunteers, Infections, Influenza, Human, +5 more
Locations: University of Mississippi Medical Center Jackson, Mississippi, United States

View Trial Details

Completed

A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years

NCT06573281

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: GSK Investigational Site Rolling Hills Estates, California, United States

GSK Investigational Site Atlanta, Georgia, United States

GSK Investigational Site Lenexa, Kansas, United States

GSK Investigational Site Omaha, Nebraska, United States

View Trial Details

Completed

A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults

NCT05397119

Conditions: Infections, Influenza, Human, Influenza, Pandemic, +5 more
Locations: Center for Vaccine Development and Global Health, University of Maryland School of Medicine Baltimore, Maryland, United States

View Trial Details

Completed

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

NCT03999996

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +8 more
Locations: AES - DRS - Optimal Research Alabama - Huntsville Huntsville, Alabama, United States

AES - DRS - Optimal Research Illinois - Peoria Peoria, Illinois, United States

Alliance for Multispecialty Research, LLC - Newton - PPDS Newton, Kansas, United States

Optima Research Rockville, Maryland, United States

View Trial Details

Completed

Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years

NCT05514002

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: University of Arizona Tucson, Arizona, United States

Florida A&M University Tallahassee, Florida, United States

Baylor College of Medicine Houston, Texas, United States

University of Utah Salt Lake City, Utah, United States

View Trial Details

Completed

Phase I/II Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose)

NCT07737106

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Urad Middle Banner Center for Disease Control and Prevention Bayan Nur, Inner Mongolia, China

View Trial Details

Completed

Immunogenicity of Influenza Vaccinations

NCT06518577

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Valleywise Health Comprehensive Health Center Phoenix, Arizona, United States

ASU Biodesign Institute Tempe, Arizona, United States

Centers for Disease Control and Prevention Atlanta, Georgia, United States

Washington University IDCRU St Louis, Missouri, United States

View Trial Details

Completed

An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection

NCT04494412

Conditions: Arthralgia, Infections, Influenza, Human, +11 more
Locations: GSK Investigational Site Florence, Italy

GSK Investigational Site Messina, Italy

GSK Investigational Site Roma, Italy

GSK Investigational Site Bydgoszcz, Poland

View Trial Details

Completed

Different Treatment Options Used for Post Covid-19 Syndrome

NCT07722000

Conditions: COVID-19, Chronic Disease, Coronaviridae Infections, +18 more
Locations: Beni Suef University Banī Suwayf, Beni Suweif Governorate, Egypt

View Trial Details

RNA Virus Infections

RNA Virus Infections trial results

Related conditions